Differential tissue-specific function of Adora2b in cardioprotection

Journal of Immunology

Volumn 195, Issue 4, 2015, Pages 1732-1743

  Seo, Seong Wook ^a,b   Koeppen, Michael ^a,c   Bonney, Stephanie ^a   Gobel, Merit ^a   Thayer, Molly ^a   Harter, Patrick N ^d   Ravid, Katya ^e   Eltzschig, Holger K ^a   Mittelbronn, Michel ^d   Walker, Lori ^f   Eckle, Tobias ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Kyung Hee University Hospital   (South Korea)

^c UNIVERSITY OF MUNICH   (Germany)

^d GOETHE UNIVERSITY   (Germany)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2B RECEPTOR; CYTOKINE; TROPONIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATORY CELL; ISCHEMIC PRECONDITIONING; MALE; MOUSE; MUSCLE CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; ADOPTIVE TRANSFER; ANIMAL; ANTIBODY SPECIFICITY; BONE MARROW CELL; CARDIAC MUSCLE CELL; DISEASE MODEL; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; HEART INFARCTION PREVENTION; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; PATHOLOGY;

ADOPTIVE TRANSFER; ANIMALS; BONE MARROW CELLS; DISEASE MODELS, ANIMAL; ENDOTHELIUM; GENE DELETION; GENE EXPRESSION REGULATION; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MICE; MICE, KNOCKOUT; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; NEUTROPHILS; ORGAN SPECIFICITY; RECEPTOR, ADENOSINE A2B; SIGNAL TRANSDUCTION;

EID: 84938920846     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402288     Document Type: Article

References (61)

1. Go, A. S., D. Mozaffarian, V. L. Roger, E. J. Benjamin, J. D. Berry, M. J. Blaha, S. Dai, E. S. Ford, C. S. Fox, S. Franco, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. 2014. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 129: e28-e292.
2. Eltzschig, H. K., and T. Eckle. 2011. Ischemia and reperfusion-from mechanism to translation. Nat. Med. 17: 1391-1401.
3. Go, A. S., D. Mozaffarian, V. L. Roger, E. J. Benjamin, J. D. Berry, M. J. Blaha, S. Dai, E. S. Ford, C. S. Fox, S. Franco, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. 2014. Executive summary: heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 129: 399-410.
4. Peart, J. N., and J. P. Headrick. 2007. Adenosinergic cardioprotection: multiple receptors, multiple pathways. Pharmacol. Ther. 114: 208-221.
5. Linden, J. 2001. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 41: 775-787.
6. Eltzschig, H. K. 2009. Adenosine: an old drug newly discovered. Anesthesiology 111: 904-915.
7. Koeppen, M., T. Eckle, and H. K. Eltzschig. 2011. Interplay of hypoxia and A2B adenosine receptors in tissue protection. Adv. Pharmacol. 61: 145-186.
8. Idzko, M., D. Ferrari, and H. K. Eltzschig. 2014. Nucleotide signalling during inflammation. Nature 509: 310-317.
9. Eltzschig, H. K., S. K. Bonney, and T. Eckle. 2013. Attenuating myocardial ischemia by targeting A2B adenosine receptors. Trends Mol. Med. 19: 345-354.
10. Eltzschig, H. K. 2013. Targeting purinergic signaling for perioperative organ protection. Anesthesiology 118: 1001-1004.
11. Kuno, A., S. D. Critz, L. Cui, V. Solodushko, X. M. Yang, T. Krahn, B. Albrecht, S. Philipp, M. V. Cohen, and J. M. Downey. 2007. Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion. J. Mol. Cell. Cardiol. 43: 262-271.
12. Eckle, T., T. Krahn, A. Grenz, D. Köhler, M. Mittelbronn, C. Ledent, M. A. Jacobson, H. Osswald, L. F. Thompson, K. Unertl, and H. K. Eltzschig. 2007. Cardioprotection by ecto-59-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115: 1581-1590.
13. Philipp, S., X. M. Yang, L. Cui, A. M. Davis, J. M. Downey, and M. V. Cohen. 2006. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc. Res. 70: 308-314.
14. Granfeldt, A., D. J. Lefer, and J. Vinten-Johansen. 2009. Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc. Res. 83: 234-246.
15. Frank, A., M. Bonney, S. Bonney, L. Weitzel, M. Koeppen, and T. Eckle. 2012. Myocardial ischemia reperfusion injury: from basic science to clinical bedside. Semin. Cardiothorac. Vasc. Anesth. 16: 123-132.
16. Eckle, T. 2014. About dogs, mice, and men: from ischemic preconditioning to anesthetic postconditioning of the heart. Semin. Cardiothorac. Vasc. Anesth. 18: 247-248.
17. Koeppen, M., P. N. Harter, S. Bonney, M. Bonney, S. Reithel, C. Zachskorn, M. Mittelbronn, and T. Eckle. 2012. Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injury. Anesthesiology 116: 1245-1257.
18. Eckle, T., D. Köhler, R. Lehmann, K. El Kasmi, and H. K. Eltzschig. 2008. Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 118: 166-175.
19. Eckle, T., K. Hartmann, S. Bonney, S. Reithel, M. Mittelbronn, L. A. Walker, B. D. Lowes, J. Han, C. H. Borchers, P. M. Buttrick, et al. 2012. Adora2belicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat. Med. 18: 774-782.
20. Eckle, T., A. Grenz, S. Laucher, and H. K. Eltzschig. 2008. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J. Clin. Invest. 118: 3301-3315.
21. Clausen, B. E., C. Burkhardt, W. Reith, R. Renkawitz, and I. Förster. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8: 265-277.
22. Alva, J. A., A. C. Zovein, A. Monvoisin, T. Murphy, A. Salazar, N. L. Harvey, P. Carmeliet, and M. L. Iruela-Arispe. 2006. VE-cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev. Dyn. 235: 759-767.
23. Hall, M. E., G. Smith, J. E. Hall, and D. E. Stec. 2011. Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice. Am. J. Physiol. Heart Circ. Physiol. 301: H253-H260.
24. Dewald, O., N. G. Frangogiannis, M. P. Zoerlein, G. D. Duerr, G. Taffet, L. H. Michael, A. Welz, and M. L. Entman. 2004. A murine model of ischemic cardiomyopathy induced by repetitive ischemia and reperfusion. Thorac. Cardiovasc. Surg. 52: 305-311.
25. Eckle, T., A. Grenz, D. Köhler, A. Redel, M. Falk, B. Rolauffs, H. Osswald, F. Kehl, and H. K. Eltzschig. 2006. Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am. J. Physiol. Heart Circ. Physiol. 291: H2533-H2540.
26. Eckle, T., M. Koeppen, and H. Eltzschig. 2011. Use of a hanging weight system for coronary artery occlusion in mice. J. Vis. Exp. 50: pii: 2526.
27. Yang, D., Y. Zhang, H. G. Nguyen, M. Koupenova, A. K. Chauhan, M. Makitalo, M. R. Jones, C. St Hilaire, D. C. Seldin, P. Toselli, et al. 2006. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J. Clin. Invest. 116: 1913-1923.
28. Daley, J. M., A. A. Thomay, M. D. Connolly, J. S. Reichner, and J. E. Albina. 2008. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83: 64-70.
29. Yamamoto, S., R. G. Nava, J. Zhu, H. J. Huang, M. Ibrahim, T. Mohanakumar, M. J. Miller, A. S. Krupnick, D. Kreisel, and A. E. Gelman. 2012. Cutting edge: Pseudomonas aeruginosa abolishes established lung transplant tolerance by stimulating B7 expression on neutrophils. J. Immunol. 189: 4221-4225.
30. Salman, S., S. Kumbasar, Y. Kumtepe, M. Karaca, B. Borekci, K. Yildirim, H. H. Alp, E. Cadirci, and H. Suleyman. 2011. Role of adrenal gland hormones in the anti-inflammatory effect mechanism of tamoxifen, a partial antagonist for oestrogen receptors, and relation with COX levels. Gynecol. Endocrinol. 27: 241-247.
31. Thompson, A. A., P. M. Elks, H. M. Marriott, S. Eamsamarng, K. R. Higgins, A. Lewis, L. Williams, S. Parmar, G. Shaw, E. E. McGrath, et al. 2014. Hypoxiainducible factor 2a regulates key neutrophil functions in humans, mice, and zebrafish. Blood 123: 366-376.
32. Headrick, J. P., and R. D. Lasley. 2009. Adenosine receptors and reperfusion injury of the heart. Handb. Exp. Pharmacol. 193: 189-214.
33. Bonney, S., K. Hughes, and T. Eckle. 2014. Anesthetic cardioprotection: the role of adenosine. Curr. Pharm. Des. 20: 5690-5695.
34. Bonney, S., K. Hughes, P. N. Harter, M. Mittelbronn, L. Walker, and T. Eckle. 2013. Cardiac period 2 in myocardial ischemia: clinical implications of a light dependent protein. Int. J. Biochem. Cell Biol. 45: 667-671.
35. Bonney, S., D. Kominsky, K. Brodsky, H. Eltzschig, L. Walker, and T. Eckle. 2013. Cardiac Per2 functions as novel link between fatty acid metabolism and myocardial inflammation during ischemia and reperfusion injury of the heart. PLoS ONE 8: e71493.
36. Eckle, T., and H. K. Eltzschig. 2011. Toll-like receptor signaling during myocardial ischemia. Anesthesiology 114: 490-492.
37. Eckle, T., M. Faigle, A. Grenz, S. Laucher, L. F. Thompson, and H. K. Eltzschig. 2008. A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111: 2024-2035.
38. Warth, A., T. Eckle, D. Köhler, M. Faigle, S. Zug, K. Klingel, H. K. Eltzschig, and H. Wolburg. 2007. Upregulation of the water channel aquaporin-4 as a potential cause of postischemic cell swelling in a murine model of myocardial infarction. Cardiology 107: 402-410.
39. Cohen, M. V., and J. M. Downey. 2008. Adenosine: trigger and mediator of cardioprotection. Basic Res. Cardiol. 103: 203-215.
40. Reichelt, M. E., L. Willems, J. G. Molina, C. X. Sun, J. C. Noble, K. J. Ashton, J. Schnermann, M. R. Blackburn, and J. P. Headrick. 2005. Genetic deletion of the A1 adenosine receptor limits myocardial ischemic tolerance. Circ. Res. 96: 363-367.
41. Yang, Z., Y. J. Day, M. C. Toufektsian, S. I. Ramos, M. Marshall, X. Q. Wang, B. A. French, and J. Linden. 2005. Infarct-sparing effect of A2A-adenosine receptor activation is due primarily to its action on lymphocytes. Circulation 111: 2190-2197.
42. Headrick, J. P., N. S. Gauthier, S. S. Berr, R. R. Morrison, and G. P. Matherne. 1998. Transgenic A1 adenosine receptor overexpression markedly improves myocardial energy state during ischemia-reperfusion. J. Mol. Cell. Cardiol. 30: 1059-1064.
43. Wan, T. C., Z. D. Ge, A. Tampo, Y. Mio, M. W. Bienengraeber, W. R. Tracey, G. J. Gross, W. M. Kwok, and J. A. Auchampach. 2008. The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-39-aminoadenosine-59-Nmethylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel. J. Pharmacol. Exp. Ther. 324: 234-243.
44. Kuno, A., N. V. Solenkova, V. Solodushko, T. Dost, Y. Liu, X. M. Yang, M. V. Cohen, and J. M. Downey. 2008. Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C. Am. J. Physiol. Heart Circ. Physiol. 295: H1288-H1295.
45. Yang, X., W. Xin, X. M. Yang, A. Kuno, T. C. Rich, M. V. Cohen, and J. M. Downey. 2011. A2B adenosine receptors inhibit superoxide production from mitochondrial complex I in rabbit cardiomyocytes via a mechanism sensitive to Pertussis toxin. Br. J. Pharmacol. 163: 995-1006.
46. Grube, K., J. Rüdebusch, Z. Xu, T. Böckenholt, C. Methner, T. Müller, F. Cuello, K. Zimmermann, X. Yang, S. B. Felix, et al. 2011. Evidence for an intracellular localization of the adenosine A2B receptor in rat cardiomyocytes. Basic Res. Cardiol. 106: 385-396.
47. Heusch, G., K. Boengler, and R. Schulz. 2010. Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection. Basic Res. Cardiol. 105: 151-154.
48. Diaz, R. J., and G. J. Wilson. 2006. Studying ischemic preconditioning in isolated cardiomyocyte models. Cardiovasc. Res. 70: 286-296.
49. Stubbs, S. L., S. T. Hsiao, H. M. Peshavariya, S. Y. Lim, G. J. Dusting, and R. J. Dilley. 2012. Hypoxic preconditioning enhances survival of human adiposederived stem cells and conditions endothelial cells in vitro. Stem Cells Dev. 21: 1887-1896.
50. Wu, X. D., Z. Y. Zhang, S. Sun, Y. Z. Li, X. R. Wang, X. Q. Zhu, W. H. Li, and X. H. Liu. 2013. Hypoxic preconditioning protects microvascular endothelial cells against hypoxia/reoxygenation injury by attenuating endoplasmic reticulum stress. Apoptosis 18: 85-98.
51. Sarkar, K., Z. Cai, R. Gupta, N. Parajuli, K. Fox-Talbot, M. S. Darshan, F. J. Gonzalez, and G. L. Semenza. 2012. Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning. Proc. Natl. Acad. Sci. USA 109: 10504-10509.
52. Eltzschig, H. K., and C. D. Collard. 2004. Vascular ischaemia and reperfusion injury. Br. Med. Bull. 70: 71-86.
53. Yellon, D. M., and D. J. Hausenloy. 2007. Myocardial reperfusion injury. N. Engl. J. Med. 357: 1121-1135.
54. Eltzschig, H. K., J. C. Ibla, G. T. Furuta, M. O. Leonard, K. A. Jacobson, K. Enjyoji, S. C. Robson, and S. P. Colgan. 2003. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198: 783-796.
55. van der Hoeven, D., T. C. Wan, E. T. Gizewski, L. M. Kreckler, J. E. Maas, J. Van Orman, K. Ravid, and J. A. Auchampach. 2011. A role for the low-affinity A2B adenosine receptor in regulating superoxide generation by murine neutrophils. J. Pharmacol. Exp. Ther. 338: 1004-1012.
56. Csóka, B., Z. H. Németh, P. Rosenberger, H. K. Eltzschig, Z. Spolarics, P. Pacher, Z. Selmeczy, B. Koscsó, L. Himer, E. S. Vizi, et al. 2010. A2B adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation. J. Immunol. 185: 542-550.
57. Chen, H., D. Yang, S. H. Carroll, H. K. Eltzschig, and K. Ravid. 2009. Activation of the macrophage A2b adenosine receptor regulates tumor necrosis factor-alpha levels following vascular injury. Exp. Hematol. 37: 533-538.
58. Xiang, F. L., X. Lu, L. Hammoud, P. Zhu, P. Chidiac, J. Robbins, and Q. Feng. 2009. Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice. Circulation 120: 1065-1074.
59. Frangogiannis, N. G., C. W. Smith, and M. L. Entman. 2002. The inflammatory response in myocardial infarction. Cardiovasc. Res. 53: 31-47.
60. Hofer, M., A. Vacek, M. Posp?sil, L. Weiterová, J. Holá, D. Streitová, and V. Znojil. 2006. Adenosine potentiates stimulatory effects on granulocytemacrophage hematopoietic progenitor cells in vitro of IL-3 and SCF, but not those of G-CSF, GM-CSF and IL-11. Physiol. Res. 55: 591-596.
61. Wakeno, M., T. Minamino, O. Seguchi, H. Okazaki, O. Tsukamoto, K. Okada, A. Hirata, M. Fujita, H. Asanuma, J. Kim, et al. 2006. Long-term stimulation of adenosine A2b receptors begun after myocardial infarction prevents cardiac remodeling in rats. Circulation 114: 1923-1932.